ATX has attracted substantial interest over the last decade as a potential therapeutic target since the ATX-LPA axis was shown to play a key role in a variety of physiological and pathological conditions including fibrotic diseases, arthritis, glaucoma, and a number of other disorders (Matralis et al., 2019). The gene discussed is LPA; the disease is glaucoma.